AGP Executive Report
Last update: 7 hours agoTobacco & Nicotine Use: Greece still leads the EU in daily tobacco/nicotine use, with 22.6% of adults reporting everyday consumption in 2025—well above the EU average (16.5%) and only slowly improving. Drug Safety & Public Health: Bulgarian authorities dismantled the country’s first documented fentanyl manufacturing facility in Sofia’s Fakulteta, arresting three men; experts warn the spread could fuel an “epidemic” of overdoses. Humanitarian Health Access: MPs heard the mother of Iva Mihaylova, who says she’s been blocked from receiving medical treatment in Bulgaria for 10 months after a crash—raising fresh pressure on cross-border care decisions. Severe Asthma Research: A global real-world study links easier access to biologic treatments with higher remission rates and better clinical outcomes in severe asthma. Heat & Immune Health: Bulgarian immunologist warns that longer heatwaves and extreme heat strain thermoregulation and can worsen immune and chronic conditions, including cardiovascular risks. Vaccines Without Refrigeration: Phase I results were published for SPVX02, a fridge-free Td vaccine candidate stable for 24 months at 30°C, aiming to improve access and logistics. Healthcare Funding: Bulgaria secured remaining NRRP funding, including support for hospital upgrades and a new endovascular stroke-diagnosis centre. Infectious Disease Watch: Experts say West Nile fever season may peak later, with cases in Bulgaria still likely.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
